Healthy Business Matters: GLP-1's Alone Are Not a Metabolic Strategy episode artwork

EPISODE · Feb 24, 2026 · 15 MIN

Healthy Business Matters: GLP-1's Alone Are Not a Metabolic Strategy

from Healthy Business Matters

GLP-1s are powerful.They reduce appetite.They lower A1C.They drive meaningful weight loss.For many patients, they are clinically appropriate and life-changing.What’s controversial isn’t the drug.It’s how employers are deploying it.In too many health plans, GLP-1s are being used as the metabolic strategy instead of as a tool inside one. And those are not the same thing.In this episode, Dr. Andrew White breaks down why weight loss alone does not equal metabolic durability and why employers who ignore sequencing, movement capacity, and off-ramps may be increasing long-term pharmacy exposure instead of reducing risk.If you’re a CFO, broker, HR leader, or operator evaluating GLP-1 coverage, this episode gives you a practical framework you can use in your next renewal meeting.What You’ll LearnWhy GLP-1s reduce calories but don’t automatically restore movement capacityThe difference between weight loss and metabolic resilienceWhy skeletal muscle is the real metabolic insurance policyThe five-step sequence required for a true employer metabolic strategyWhy most GLP-1 vendors avoid discussing discontinuationThe blind spot almost no GLP-1 programs track: strength and muscle preservationFive hard questions every CFO should ask before approving coverageThe 5-Step Metabolic Strategy FrameworkRemove inhibitors of movementRestore movement capacityImprove insulin sensitivity intentionallyDefine the pharmacology off-ramp before startingReduce long-term pharmacy dependencyBecause if the drug stops and the risk returns, you didn’t change the pathway you suppressed a symptomWho This Episode Is ForSelf-funded employersCFOs evaluating pharmacy exposureBrokers navigating competitive GLP-1 pressureHR leaders caught between recruitment demands and long-term cost controlIf you care about reducing risk instead of managing optics, this episode is for you.About the HostDr. Andrew White is the Founder and CEO of AlignWell, a national MSK and metabolic risk management company working with self-funded employers to reduce long-term claims exposure by changing where care starts and how risk is sequenced.If this episode sharpened your thinking:Share it with a broker or CFO who needs a clearer frameworkFollow/subscribe on Apple or Spotify so you don’t miss future episodesSend topic ideas or renewal questions to [email protected] Business Matters is built for people who make real decisions.Clear thinking. Better incentives. Healthier businesses.

Episode metadata supplied by the publisher feed · Published Feb 24, 2026

Embed this episode

NOW PLAYING

Healthy Business Matters: GLP-1's Alone Are Not a Metabolic Strategy

0:00 15:40

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Healthy Business Matters?

This episode is 15 minutes long.

When was this Healthy Business Matters episode published?

This episode was published on February 24, 2026.

Can I download this Healthy Business Matters episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!